Literature DB >> 2960976

Fractionation of HeLa cell nuclear extracts reveals minor small nuclear ribonucleoprotein particles.

A Krämer1.   

Abstract

Upon chromatographic fractionation of HeLa cell nuclear extracts, small RNAs of 145 and 66/65 nucleotides, respectively, were detected that are distinct from the abundant small RNAs present in the extract. These RNAs are precipitated by antibodies directed against the trimethylguanosine cap structure, characteristic for small nuclear RNAs (snRNAs) of the U type. The RNAs of 145 and 66/65 nucleotides appear to be associated with at least one of the proteins common to the major small nuclear ribonucleoprotein particles U1 to U6, since they are specifically bound by anti-Sm antibodies. These criteria characterize the RNAs that are 145 and 66/65 nucleotides in length as U-type snRNAs. Upon gel filtration, the RNAs are found within particles of molecular weights approximately equal to 150,000 and 115,000, respectively. The RNA of 145 nucleotides represents a different minor snRNA, designated U11, whereas the RNA of 66/65 nucleotides may correspond to either mammalian U7 or U10 RNA.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2960976      PMCID: PMC299552          DOI: 10.1073/pnas.84.23.8408

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  33 in total

1.  Splicing of in vitro synthesized messenger RNA precursors in HeLa cell extracts.

Authors:  N Hernandez; W Keller
Journal:  Cell       Date:  1983-11       Impact factor: 41.582

2.  Antibodies elicited by N2,N2-7-trimethylguanosine react with small nuclear RNAs and ribonucleoproteins.

Authors:  J H Smith; G L Eliceiri
Journal:  J Biol Chem       Date:  1983-04-10       Impact factor: 5.157

3.  5'-terminal caps of snRNAs are accessible for reaction with 2,2,7-trimethylguanosine-specific antibody in intact snRNPs.

Authors:  P Bringmann; R Reuter; J Rinke; B Appel; R Bald; R Lührmann
Journal:  J Biol Chem       Date:  1983-03-10       Impact factor: 5.157

4.  3'-terminal labelling of RNA with T4 RNA ligase.

Authors:  T E England; O C Uhlenbeck
Journal:  Nature       Date:  1978-10-12       Impact factor: 49.962

5.  Antibodies to small nuclear RNAs complexed with proteins are produced by patients with systemic lupus erythematosus.

Authors:  M R Lerner; J A Steitz
Journal:  Proc Natl Acad Sci U S A       Date:  1979-11       Impact factor: 11.205

6.  Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei.

Authors:  J D Dignam; R M Lebovitz; R G Roeder
Journal:  Nucleic Acids Res       Date:  1983-03-11       Impact factor: 16.971

7.  Isolation and characterization of rabbit anti-m3 2,2,7G antibodies.

Authors:  R Luhrmann; B Appel; P Bringmann; J Rinke; R Reuter; S Rothe; R Bald
Journal:  Nucleic Acids Res       Date:  1982-11-25       Impact factor: 16.971

8.  Biochemical complementation with RNA in the Xenopus oocyte: a small RNA is required for the generation of 3' histone mRNA termini.

Authors:  G Galli; H Hofstetter; H G Stunnenberg; M L Birnstiel
Journal:  Cell       Date:  1983-10       Impact factor: 41.582

9.  Monoclonal antibodies to nucleic acid-containing cellular constituents: probes for molecular biology and autoimmune disease.

Authors:  E A Lerner; M R Lerner; C A Janeway; J A Steitz
Journal:  Proc Natl Acad Sci U S A       Date:  1981-05       Impact factor: 11.205

10.  Genetic complementation in the Xenopus oocyte: co-expression of sea urchin histone and U7 RNAs restores 3' processing of H3 pre-mRNA in the oocyte.

Authors:  K Strub; M L Birnstiel
Journal:  EMBO J       Date:  1986-07       Impact factor: 11.598

View more
  15 in total

1.  Two-step affinity purification of U7 small nuclear ribonucleoprotein particles using complementary biotinylated 2'-O-methyl oligoribonucleotides.

Authors:  H O Smith; K Tabiti; G Schaffner; D Soldati; U Albrecht; M L Birnstiel
Journal:  Proc Natl Acad Sci U S A       Date:  1991-11-01       Impact factor: 11.205

2.  Organization and transient expression of the gene for human U11 snRNA.

Authors:  C Suter-Crazzolara; W Keller
Journal:  Gene Expr       Date:  1991-05

Review 3.  New RNPs of higher eukaryotes.

Authors:  J Craft; H Gold
Journal:  Mol Biol Rep       Date:  1990       Impact factor: 2.316

4.  Pre-mRNA splicing by complementation with purified human U1, U2, U4/U6 and U5 snRNPs.

Authors:  A R Krainer
Journal:  Nucleic Acids Res       Date:  1988-10-25       Impact factor: 16.971

5.  Heat-labile regulatory factor is required for 3' processing of histone precursor mRNAs.

Authors:  O Gick; A Krämer; A Vasserot; M L Birnstiel
Journal:  Proc Natl Acad Sci U S A       Date:  1987-12       Impact factor: 11.205

6.  Poly(A) polymerase purified from HeLa cell nuclear extract is required for both cleavage and polyadenylation of pre-mRNA in vitro.

Authors:  G Christofori; W Keller
Journal:  Mol Cell Biol       Date:  1989-01       Impact factor: 4.272

7.  Herpesvirus saimiri U RNAs are expressed and assembled into ribonucleoprotein particles in the absence of other viral genes.

Authors:  S I Lee; J A Steitz
Journal:  J Virol       Date:  1990-08       Impact factor: 5.103

8.  Isolation and sequence of four small nuclear U RNA genes of Trypanosoma brucei subsp. brucei: identification of the U2, U4, and U6 RNA analogs.

Authors:  J Mottram; K L Perry; P M Lizardi; R Lührmann; N Agabian; R G Nelson
Journal:  Mol Cell Biol       Date:  1989-03       Impact factor: 4.272

9.  Schizosaccharomyces U6 genes have a sequence within their introns that matches the B box consensus of tRNA internal promoters.

Authors:  D Frendewey; I Barta; M Gillespie; J Potashkin
Journal:  Nucleic Acids Res       Date:  1990-04-25       Impact factor: 16.971

10.  Transcription processing at 1,N2-ethenoguanine by human RNA polymerase II and bacteriophage T7 RNA polymerase.

Authors:  Alexandra Dimitri; Angela K Goodenough; F Peter Guengerich; Suse Broyde; David A Scicchitano
Journal:  J Mol Biol       Date:  2007-10-30       Impact factor: 5.469

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.